Body-Worn sensors could revolutionize ataxia tracking
NCT ID NCT06628934
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses small body-worn sensors to measure movement during simple coordination tests in people with spinocerebellar ataxia, a condition that affects balance and walking. Researchers aim to see if these sensors can accurately track disease severity and progression. The study involves 600 participants, including healthy controls, and compares sensor data to patient-reported outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to measure ataxia progression using simple wearable devices, helping future treatment trials.
- What could go wrong
- This is an observational study, not testing a treatment. The sensors may not prove more useful than standard exams, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 600 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2017
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients of Ataxia Clinics
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Ataxia Group - Individuals who have a genetic-confirmation of SCA diagnosis and are able to sit or stand unassisted for 30 seconds and follow directions. * Healthy Control Group - Individuals who are able to sit or stand unassisted for 30 seconds and follow directions. Exclusion Criteria: * Any other neurological or musculoskeletal disorder not attributed to the SCA that could affect balance, gait or voluntary movement.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Spinocerebellar ataxia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Chicago
Chicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists decode gait signatures to spot brain diseases
- Could stem cells help people with spinocerebellar ataxia?
- New hope for SCA patients: expanded access to investigational drug troriluzole
- Could a drug slow rare brain disease? new study uses Real-World data to find out
- New study sheds light on vision loss in rare genetic brain disorders
- New study tracks rare disease SCA7 to uncover clues for future treatments